![Jennifer Minai-Azary](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Minai-Azary
Director of Finance/CFO at
CONTEXT THERAPEUTICS INC.
Net worth: 228 029 $ as of 2026-05-30
Profile
Jennifer Minai-Azary is currently Director at KAHR Medical Ltd. since 2022.
Jennifer is Treasurer at Millendo Therapeutics US, Inc. and Chief Financial Officer & Treasurer at Context Therapeutics, Inc. since 2021.
Former roles include Director-Technical Accounting at PAREXEL International Corp.
and Vice President-Finance at Millendo Therapeutics, Inc. from 2013 to 2021.
Education includes undergraduate and graduate degrees from the University of Michigan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-12 | 80,010 ( 0.09% ) | 228 029 $ | 2026-05-30 |
Jennifer Minai-Azary active positions
| Companies | Position | Start |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Director of Finance/CFO | 2021-10-31 |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic drugs | Director/Board Member | 2022-07-10 |
Millendo Therapeutics US, Inc.
 Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Treasurer | - |
Former positions of Jennifer Minai-Azary
| Companies | Position | End |
|---|---|---|
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
| MILLENDO THERAPEUTICS | Director of Finance/CFO | - |
Training of Jennifer Minai-Azary
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic drugs | Health Technology |
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Context Therapeutics, Inc.
 Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
- Stock Market
- Insiders
- Jennifer Minai-Azary
